Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-02-06 @ 10:33 AM
Study NCT ID:
NCT03941093
Status:
COMPLETED
Last Update Posted:
2024-11-05
First Post:
2019-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer
Sponsor:
FibroGen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-02
First Submit QC Date:
None
Study First Post Date:
2019-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-10-15
Results First Submit QC Date:
None
Results First Post Date:
2024-11-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-15
Last Update Post Date:
2024-11-05
Last Update Post Date Type:
ACTUAL